Author

M.-L. Fremond

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

A. Lepelley· 2 shared B. Bader-Meunier· 2 shared M. Hully· 2 shared Y. J. Crow· 2 shared A. Belot· 1 shared A. Dhir· 1 shared A. Fischer· 1 shared B. Callewaert· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Lepelley

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintFeb 23, 2023

Enhanced inflammatory signaling driven by metabolic switch in Aicardi-Goutieres syndrome

M. Batignes, M. Luka, S. Jagtap…·M. M. Menager

This study identifies a metabolic switch and loss of HIF-1 activity in AGS patients, showing that stabilizing HIF-1 reduces inflammation and IP-10 production.

DOI 10.1101/2023.02.23.529707

humanscRNA-seq

𝕏 PostBluesky

ImmunologybioRxivApr 2, 2021

Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A

A. Lepelley, E. Della Mina, E. Van Nieuwenhove…·Y. J. Crow

The paper identifies mutations in ATAD3A causing enhanced type I interferon signaling in patients with neurological and autoimmune features.

DOI 10.1084/jem.20201560

humanbulk RNA-seq

𝕏 PostBluesky